The use of pericyazine and chlorpromazine with disturbed mentally subnormal patients

Weir, T. W. H.; Kernohan, G. A.; MacKay, D. N.; Weir, T W
January 1968
British Journal of Psychiatry;Jan68, Vol. 114 Issue 506, p111
Academic Journal
journal article
The article presents an abstract of the study "The Use of Pericyazine and Chlorpromazine with Disturbed Mentally Subnormal Patients." It describes a clinical trial in which pericyazine and chlorpromazine were administered by the 45 disturbed mentally subnormal resident patients. The study suggests that the active-syrup and inert-syrup conditions were insignificant for both pericyazine and chlorpromazine, irrespective of which method of analyzing the data was used.


Related Articles

  • COMPARISON OF PSYCHO-THERAPEUTIC AND ANTHELMINTIC ACTIVITIES. Minchin, R. L. H.; Holdaway, Ian; MINCHIN, R L; HOLDAWAY, I // British Journal of Psychiatry;May64, Vol. 110 Issue 466, p411 

    The article cites a study that explores the anthelmintic activity of phenothiazine drugs used in patients with mental disorders. The study was aimed at discovering whether the activity of phenothiazine matched the drugs' potency for psychotic patients. The authors inferred that testing drugs for...

  • Clopenthixol decanoate in the management of aggressive mentally handicapped patients. Mlele, T. J. J.; Wiley, Yvonne V.; Mlele, T J; Wiley, Y V // British Journal of Psychiatry;Sep86, Vol. 149, p373 

    The article presents the results of preliminary observations of the clinical use of clopenthixol decanoate in the management of aggressive and disruptive mentally handicapped patients. Ten patients treated for behavior disorders at the Stoke Park Group of Hospitals in England were included. The...

  • CRIMSON [CRisis plan IMpact: Subjective and Objective coercion and eNgagement] Protocol: A randomised controlled trial of joint crisis plans to reduce compulsory treatment of people with psychosis. Thornicroft, Graham; Farrelly, Simone; Birchwood, Max; Marshall, Max; Szmukler, George; Waheed, Waquas; Byford, Sarah; Dunn, Graham; Henderson, Claire; Lester, Helen; Leese, Morven; Rose, Diana; Sutherby, Kim // Trials;2010, Vol. 11, p102 

    Background: The use of compulsory treatment under the Mental Health Act (MHA) has continued to rise in the UK and in other countries. The Joint Crisis Plan (JCP) is a statement of service users' wishes for treatment in the event of a future mental health crisis. It is developed with the clinical...

  • Financial Impact of Housing the Mentally Ill. DeFerrari, Nancy // American Jails;Nov/Dec2010, Vol. 24 Issue 5, p30 

    The article focuses on the impact of the financial problem in housing the mentally ill to the population of jail in Florida. The inefficiency of thorazine to cure the mentally ill and the lack of financial support from the government have led to the increase in jail population. The partnership...

  • Pseudodementia in the Mentally Retarded. Myers, Beverly A.; Pueschel, Siegfried M. // Clinical Pediatrics;May1987, Vol. 26 Issue 5, p275 

    Intellectual and behavioral deterioration in an individual who is mentally retarded presents a diagnostic challenge to the clinician, since the deterioration may be the result of the primary disorder or a new process. The mentally retarded individual's limitations in communication make the...

  • Use of the evidence base in substance abuse treatment programs for American Indians and Alaska natives: pursuing quality in the crucible of practice and policy. Novins, Douglas K.; Aarons, Gregory A.; Conti, Sarah G.; Dahlke, Dennis; Daw, Raymond; Fickenscher, Alexandra; Fleming, Candace; Love, Craig; Masis, Kathleen; Spicer, Paul // Implementation Science;2011, Vol. 6 Issue 1, p63 

    Background: A variety of forces are now shaping a passionate debate regarding the optimal approaches to improving the quality of substance abuse services for American Indian and Alaska Native communities. While there have been some highly successful efforts to meld the traditions of American...

  • Autism - Pipeline Review, H2 2011.  // Biomedical Market Newsletter;11/7/2011, Vol. 21, p690 

    The article provides an overview of the autism therapeutic pipeline for 2011. It offers information on the therapeutic development for the developmental disability, including updates and features on late-stage and discontinued projects. Moreover, the report covers a snapshot on the global...

  • Why do we need randomised controlled trials to assess... Stephenson, Judith; Imrie, John // BMJ: British Medical Journal (International Edition);02/21/98, Vol. 316 Issue 7131, p611 

    Considers the merits and limitations of randomized controlled trials in the behavioral area compared with clinical medicine. How these trials can be applied successfully to assess behavioral interventions; Merits and limitations of randomized controlled trials; Forms of randomized controlled...

  • What You Need to Know Before Becoming A Human Subject in a Clinical Trial.  // Health Letter;Mar2013, Vol. 29 Issue 3, p1 

    The article focuses on the things that patients and individuals should know before participating in a clinical trial, which include the difference between clinical care and a clinical trial.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics